JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B8681 Fenoldopam (mesylate)

insoluble in EtOH; ≥10.8 mg/mL
A3282 Cariprazine

Summary: D2/D3 partial agonist,antipsychotic drug
B5639 A 412997 dihydrochloride

Summary: Selective D4 agonist

<38.23 mg/mL
B5795 PAOPA

Summary: dopamine D2 receptor modulator

<25.43 mg/mL
B6030 SKF38393 HCl

Summary: dopamine D1 receptor agonist

≥29.2 mg/mL
B6132 Fluphenazine dihydrochloride

Summary: phenothiazine-class D1DR and D2DR inhibitor

≥114.2 mg/mL
B6157 Perphenazine

Summary: A dopamine antagonist
B7825 Benocyclidine

Summary: dopamine reuptake inhibitor

Soluble in DMSO
C3509 Chlorprothixene (hydrochloride)

Summary: dopamine D2 receptor antagonist and GABAA receptor inhibitor

≥16.75 mg/mL
C3837 Pimozide

Summary: dopamine receptors inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.95 mg/mL